×

Growth Reports

Growth Reports
Report Name

Neglected Tropical Diseases Drugs And Vaccines Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disease (Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus), By Product (Drugs, Vaccines), Countries and Companies Report

Neglected Tropical Diseases Drugs And Vaccines Market is projected to register a 5.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021356  |   No. of Pages: 192

Neglected Tropical Disease Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disease (Dengue, Rabies, Trachoma, Buruli ulcer, Yaws, Leprosy, Chagas disease, Human African trypanosomiasis, Leishmaniases, Soil-transmitted helminthiases, Others), By Product (Drugs, Vaccines), Countries and Companies Report

Neglected Tropical Disease Treatment Market is projected to register a 4.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021355  |   No. of Pages: 209

Needle Holders Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Olsen-Hegar Needle Holder, Mayo-Hegar Needle Holder, Derf Needle Holder, Halsey Needle Holder, Mathieu Needle Holder, Crilewood Needle Holder, Webster Needle Holder, Others), By Application (Cardiovascular, Ophthalmic, Urology, Orthopedic, Dental, Gynecology, Laparoscopic, Others), By End-user (Hospitals, Ambulatory Surgical centers, Others), Countries and Companies Report

Needle Holders Market is projected to register a 11.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021354  |   No. of Pages: 185

Nasogastric Tube Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Small-bore feeding tubes, Large-bore feeding tubes), By Indication (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Others), By Patient (Adult, Pediatric, Geriatric), By End-user (Hospitals & Nursing Homes, Home Care), Countries and Companies Report

Nasogastric Tube Market is projected to register a 5.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021353  |   No. of Pages: 204

Narcolepsy Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Narcolepsy with cataplexy, Narcolepsy without cataplexy, Secondary narcolepsy), By Product (Central nervous system stimulants, Sodium Oxybate, Selective serotonin reuptake inhibitor, Tricyclic antidepressants, Others), Countries and Companies Report

Narcolepsy Therapeutics Market is projected to register a 8.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021352  |   No. of Pages: 201

Nanoparticles Metal and Metal Oxides Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Alumina Nanoparticles, Gadolinium Oxide Nanoparticles, Others), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro Assays, Cell & Phantom Imaging), Countries and Companies Report

Nanoparticles Metal and Metal Oxides Market is projected to register a 13.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021351  |   No. of Pages: 203

Nanomedicine Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Therapeutics, in-vitro Diagnostics, Drug Delivery, In-vivo Imaging, Implants), By Indication (Clinical Oncology, Infectious diseases, Clinical Cardiology, Orthopedics, Others), By Molecule (Nanoparticles, Nanoshells, Nanotubes, Nanodevices), Countries and Companies Report

Nanomedicine Market is projected to register a 12.4% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021350  |   No. of Pages: 185

Nanomedical Devices And Therapeutic Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Infectious Diseases, Inflammatory Diseases, Oncology, Central Nervous System Disorders, Cardiovascular Diseases, Others), Countries and Companies Report

Nanomedical Devices And Therapeutic Market is projected to register a 13.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021349  |   No. of Pages: 209

Myeloproliferative Disorders Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia , Chronic Eosinophilic Leukemia, Systemic Masto Cytosis), By Drug (JAK2 Inhibitors, Anti-Neoplastics, Demethylation Agents, Imatinib Mesylate, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Stores, Drug Stores), Countries and Companies Report

Myeloproliferative Disorders Drugs Market is projected to register a 4.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021347  |   No. of Pages: 191

Myelodysplastic Syndrome Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Therapeutic Class (Hypomethylating Agents, Immunomodulatory Drugs, Anti-Anemics), By Type Of Syndrome (Refractory Cytopenia With Multilineage Dysplasia, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts), By Route of Administration (Oral, Parenteral), By Application (Original, Generics), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers), Countries and Companies Report

Myelodysplastic Syndrome Drugs Market is projected to register a 9.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021346  |   No. of Pages: 208

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us